BioSpace News Archive

Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels

Albert Einstein Cancer Center (AECC), Albert Einstein College of Medicine, and Montefiore Health System today announced that leading cancer biologist Julio Aguirre-Ghiso, Ph.D., has been named founding director of the Cancer Dormancy and Tumor Microenvironment Institute (CDTMI),

Bioventus Inc.today announced that second quarter of fiscal year 2021 financial results will be released after the market closes on Tuesday, August 10, 2021.

Novan, Inc. (the “Company” or “Novan”) (NASDAQ: NOVN) today announced a proposed underwritten public offering of its common stock (the “Offering”).

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced a publication titled, “Nonmedical Use of Xtampza® ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-world Data from the Addiction Severity Index – Multimedia Version (ASI-MV®),”

Marker Therapeutics, Inc. , today announced that its Chief Financial Officer, Anthony H. Kim , will present at the upcoming virtual Raymond James Human Health Innovation Conference on Monday, June 21, 2021 at 9:20 a.m. ET.

Myomo, Inc.today announced that Paul R. Gudonis, Chief Executive Officer, and David Henry, Chief Financial Officer, will present a corporate overview of the company at the Sidoti Virtual Investor Conference on Wednesday, June 23, 2021.

Medexus Pharmaceuticals Inc. today announced its financial and operating results for the fourth quarter ending March 31, 2021.

CureVac N.V. (NASDAQ:CVAC), today announced results of the second interim analysis of its international pivotal Phase 2b/3 study in approximatively 40,000 subjects (the HERALD study) of CureVac’s first-generation COVID-19 vaccine candidate, CVnCoV

23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp., a special purpose acquisition company sponsored by Virgin Group, announced the completion of their previously announced business combination.